{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T21:33:15Z","timestamp":1717968795136},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T00:00:00Z","timestamp":1326412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00423-011-0901-9","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T05:55:11Z","timestamp":1326347711000},"page":"413-420","source":"Crossref","is-referenced-by-count":25,"title":["Parathyroidectomy for the attainment of NKF-K\/DOQI\u2122 and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism"],"prefix":"10.1007","volume":"397","author":[{"given":"Bojan","family":"Kovacevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mile","family":"Ignjatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladan","family":"Zivaljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Cuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Scepanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaklina","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Paunovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,13]]},"reference":[{"key":"901_CR1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW et al (2001) Association of elevated serum PO4, CaxPO4 product and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131\u20138","journal-title":"J Am Soc Nephrol"},{"key":"901_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519\u201330","journal-title":"Am J Kidney Dis"},{"key":"901_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium\u2009\u00d7\u2009phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607\u201317","journal-title":"Am J Kidney Dis"},{"key":"901_CR4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","volume":"11","author":"N Kimata","year":"2007","unstructured":"Kimata N, Albert JM, Akiba T et al (2007) Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study. Hemodial Int 11:340\u20138","journal-title":"Hemodial Int"},{"key":"901_CR5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW, Albert JM, Satayathum S et al (2005) Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67:1179\u201387","journal-title":"Kidney Int"},{"key":"901_CR6","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines: bone metabolism and disease in chronic kidney disease. Am J Kidney 42:S1\u2013S201","journal-title":"Am J Kidney"},{"key":"901_CR7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2215\/CJN.01060308","volume":"3","author":"MD Danese","year":"2008","unstructured":"Danese MD, Belozeroff V, Smirnakis K, Rothman KJ (2008) Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 3:1423\u20131429","journal-title":"Clin J Am Soc Nephrol"},{"key":"901_CR8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","volume":"46","author":"M Noordzij","year":"2005","unstructured":"Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT (2005) The Kidney Disease Outcomes Quality Initiative (K\/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 46:925\u2013932","journal-title":"Am J Kidney Dis"},{"key":"901_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000080087","volume":"24","author":"Z Al Aly","year":"2004","unstructured":"Al Aly Z, Gonzalez EA, Martin KJ, Gellens ME (2004) Achieving K\/DOQI laboratory target values for bone and mineral metabolism: an uphill battle. Am J Nephrol 24:422\u2013426","journal-title":"Am J Nephrol"},{"key":"901_CR10","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/ndt\/gfl006","volume":"21","author":"MD Arenas","year":"2006","unstructured":"Arenas MD, Alvarez-Ude F, Gil MT et al (2006) Application of NKF-K\/DOQI clinical practice guidelines for bone metabolism and disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant 21:1663\u20131668","journal-title":"Nephrol Dial Transplant"},{"key":"901_CR11","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516\u201325","journal-title":"N Engl J Med"},{"key":"901_CR12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","volume":"16","author":"JS Lindberg","year":"2005","unstructured":"Lindberg JS, Culleton B, Wong G et al (2005) Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 16:800\u20137","journal-title":"J Am Soc Nephrol"},{"key":"901_CR13","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfp144","volume":"24","author":"P Ure\u00f1a","year":"2009","unstructured":"Ure\u00f1a P, Jacobson SH, Zitt E et al (2009) Cinacalcet and achievement of the NKF\/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice\u2014the ECHO observational study. Nephrol Dial Transplant 24:2852\u20139","journal-title":"Nephrol Dial Transplant"},{"key":"901_CR14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","volume":"67","author":"SM Moe","year":"2005","unstructured":"Moe SM, Chertow GM, Coburn JW et al (2005) Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67:760\u201371","journal-title":"Kidney Int"},{"issue":"Suppl 113","key":"901_CR15","first-page":"S1","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD\u2013MBD). Kidney Int 76(Suppl 113):S1\u2013S130","journal-title":"Kidney Int"},{"key":"901_CR16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.surg.2010.09.009","volume":"148","author":"R Schneider","year":"2010","unstructured":"Schneider R, Kolios G, Koch BM, Fern\u00e1ndez ED, Bartsch DK, Schlosser K (2010) An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism\u2014the German perspective. Surgery 148:1091\u20139","journal-title":"Surgery"},{"key":"901_CR17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","volume":"49","author":"R Narayan","year":"2007","unstructured":"Narayan R, Perkins RM, Berbano EP et al (2007) Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 49:801\u201313","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"901_CR18","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1744-9987.2008.00627.x","volume":"12","author":"Y Tominaga","year":"2008","unstructured":"Tominaga Y, Matsuoka S, Uno N, Sato T (2008) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12(Suppl 1):S21\u2013S26","journal-title":"Ther Apher Dial"},{"key":"901_CR19","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/ndt\/gfm931","volume":"23","author":"S Mazzaferro","year":"2008","unstructured":"Mazzaferro S, Pasquali M, Farcomeni A et al (2008) Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K\/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 23:2319\u20132323","journal-title":"Nephrol Dial Transplant"},{"key":"901_CR20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5414\/CNP63284","volume":"63","author":"A Gal-Moscovici","year":"2005","unstructured":"Gal-Moscovici A, Popovtzer MM (2005) New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Clin Nephrol 63:284\u20139","journal-title":"Clin Nephrol"},{"key":"901_CR21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto DV, Moys\u00e9s RM et al (2008) K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771\u20137","journal-title":"Kidney Int"},{"key":"901_CR22","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","volume":"66","author":"B Kestenbaum","year":"2004","unstructured":"Kestenbaum B, Andress DL, Schwartz SM et al (2004) Survival following parathyroidectomy among United States dialysis patients. Kidney Int 66:2010\u20136","journal-title":"Kidney Int"},{"key":"901_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.jrn.2009.10.006","volume":"20","author":"R Dukkipati","year":"2010","unstructured":"Dukkipati R, Kovesdy CP, Colman S et al (2010) Association of relatively low serum parathyroid hormone with malnutrition\u2013inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 20:243\u201354","journal-title":"J Ren Nutr"},{"key":"901_CR24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.surg.2007.06.015","volume":"142","author":"V Costa-Hong","year":"2007","unstructured":"Costa-Hong V, Jorgetti V, Gowdak LH, Moyses RM, Krieger EM, De Lima JJ (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 142:699\u2013703","journal-title":"Surgery"},{"key":"901_CR25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0272-6386(97)90343-7","volume":"29","author":"DJ Goldsmith","year":"1997","unstructured":"Goldsmith DJ, Covic AA, Venning MC, Ackrill P (1997) Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis 29:593\u2013600","journal-title":"Am J Kidney Dis"},{"key":"901_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000045976","volume":"88","author":"G Coen","year":"2001","unstructured":"Coen G, Calabria S, Bellinghieri G et al (2001) Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia. Nephron 88:149\u201355","journal-title":"Nephron"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-011-0901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-011-0901-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-011-0901-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T21:13:29Z","timestamp":1640466809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-011-0901-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,13]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1007\/s00423-011-0901-9","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,13]]}}}